FDA approves Teva's Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia
The FDA approval letter is dated October 8; Teva says U.S. availability follows in the coming weeks.

Announced at Gemini at Work 2026, the agents act under their own Workspace identity; it is a private preview with no pricing or GA date.
The FDA approval letter is dated October 8; Teva says U.S. availability follows in the coming weeks.
In HER2CLIMB-05, median progression-free survival was 24.9 months versus 16.3 with placebo; overall survival data are immature.
The 'mito-polariton' is inferred rather than directly measured; the bioRxiv work is not peer reviewed and needs independent replication.
The arXiv preprint claims deterministic O(n^1.9992) 3SUM for bounded integers, which would refute long-standing hardness conjectures; peer review is pending.

The IP66-rated robots worked intersections and a wetland park; the company gave no figures on accuracy, uptime or traffic effects.

Aimed at classification, extraction, routing and coding subagents; available in the Claude API, AWS Bedrock, Google Cloud and Microsoft Foundry.
Talks are early; the Alphabet drug-discovery spinoff last raised a $2.1 billion Series B in May. Round size and investors are not disclosed.
The model card says it accepts up to 14 reference images and supports Search grounding; it ships in Gemini, AI Studio and the Gemini API.
Three glaucoma patients tolerated the low dose with no serious adverse events and the dose will escalate; vision signals in two are preliminary.

The deal builds demonstration sites but names no robot model, task list, fleet size or timetable for routine use.
The GitHub release spans 372 problem families with many proofs formalized in Lean; mathematicians are still assessing which results are new.